Your browser doesn't support javascript.
loading
Somatic IDH1 Hotspot Variants in Chinese Patients With Pheochromocytomas and Paragangliomas.
Li, Minghao; He, Yazhi; Pang, Yingxian; Zhang, Jing; Feng, Yu; He, Yao; Xu, Xiaowen; Wei, Yongbao; Zhong, Dewen; Deng, Wanglong; Wang, Long; Yan, Bin; Jiang, Yazhuo; Xu, Ning; Cai, Hai; Wen, Yanlin; Ning, Jinzhuo; Liu, Yujun; Gao, Xin; Shan, Zhongyan; Liu, Longfei; Teng, Xiaochun; Richter, Susan; Jiang, Jingjing.
Afiliação
  • Li M; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • He Y; Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Hospital of China Medical University, Shenyang, 110001, China.
  • Pang Y; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Zhang J; Department of Endocrinology and Metabolism, Zhongshan Hospital, Shanghai, 200032, China.
  • Feng Y; Fudan Institute for Metabolic Diseases, Fudan University, Shanghai, 200032, China.
  • He Y; Department of Endocrinology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, China.
  • Xu X; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Wei Y; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Zhong D; Shengli Clinical Medical College of Fujian Medical University and Department of Urology, Fujian Provincial Hospital, Fuzhou, 350001, China.
  • Deng W; Department of Urology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, 364000, China.
  • Wang L; Department of Urology, The First People's Hospital of Chenzhou, Chenzhou, 423000, China.
  • Yan B; Department of Urology, The Third Xiangya Hospital, Central South University, Changsha, 410013, China.
  • Jiang Y; Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, 410011, China.
  • Xu N; Department of Urology, Shaanxi Provincial People's Hospital, Xi'an, 710068, China.
  • Cai H; Department of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 361003, China.
  • Wen Y; Department of Urology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, 361003, China.
  • Ning J; Department of Urology, Nanchong Central Hospital, The Second Clinical Hospital of North Sichuan Medical College, Szechwan, 637000, China.
  • Liu Y; Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
  • Gao X; Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
  • Shan Z; Department of Endocrinology and Metabolism, Zhongshan Hospital, Shanghai, 200032, China.
  • Liu L; Fudan Institute for Metabolic Diseases, Fudan University, Shanghai, 200032, China.
  • Teng X; Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Hospital of China Medical University, Shenyang, 110001, China.
  • Richter S; Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Jiang J; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
J Clin Endocrinol Metab ; 108(5): 1215-1223, 2023 04 13.
Article em En | MEDLINE | ID: mdl-36355572
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Neoplasias das Glândulas Suprarrenais / Isocitrato Desidrogenase Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Paraganglioma / Feocromocitoma / Neoplasias das Glândulas Suprarrenais / Isocitrato Desidrogenase Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: J Clin Endocrinol Metab Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China